| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.31 | 9e-17 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-11 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-07 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-06 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |